CHG-2022-0147

Formulation Change for Lecanemabix. Formulation Change for Lecanemabix — critical change. Impacts 8 markets and 5 variations.

Change Number
CHG-2022-0147
Type
Formulation Change
Product
Lecanemabix
Status
Blocked
Owner
Lieselotte van der Berg
Initiated
2023-07-17
Description

Formulation Change for Lecanemabix — critical change

Impacted Markets (8)
US — United StatesCN — ChinaBR — BrazilDE — GermanyIT — ItalySG — SingaporeIN — IndiaPL — Poland
Impacted Modules
4.2.13.2.S
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved